We provide suggestive evidence that the C-allele of rs2014355 of ACADS associates with reduced measures of glucose-stimulated insulin release during an OGTT, indicating that the link to T2D previously suggested for this variant, may be mediated through an impaired β-oxidation of fatty acids [10]. The gene discussed is ACADS; the disease is type 2 diabetes mellitus.